Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Medpace Holdings, Inc. - Common Stock (NQ:MEDP)

649.12 -7.73 (-1.18%)
Delayed Quote Updated: 12:51 PM EST, Nov 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Medpace Holdings, Inc. - Common Stock

< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
18 19 Next >
News headline image
If You Invested $100 In This Stock 5 Years Ago, You Would Have $500 Today ↗
 
Via Benzinga
News headline image
The Investing Mosaic ↗
How do you determine what a company's worth? You start by pulling a lot of information from a lot of different places. 
Via The Motley Fool
News headline image
MEDPACE ALERT: Bragar Eagel & Squire, P.C. is Investigating Medpace Holdings, Inc. on Behalf of Medpace Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Medpace Holdings, Inc. (MEDP)
From Kirby McInerney LLP
Via Business Wire
News headline image
Looking Into Medpace Hldgs's Recent Short Interest ↗
 
Via Benzinga
News headline image
Here's How Much $100 Invested In Medpace Hldgs 5 Years Ago Would Be Worth Today ↗
 
Via Benzinga
News headline image
Expert Ratings For Medpace Hldgs ↗
 
Via Benzinga
News headline image
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Medpace Holdings, Inc. (MEDP) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
News headline image
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Medpace Holdings, Inc. (MEDP) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
News headline image
The Law Offices of Frank R. Cruz Announces Investigation of Medpace Holdings, Inc. (MEDP) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
$1000 Invested In Medpace Hldgs 5 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
News headline image
Peering Into Medpace Hldgs's Recent Short Interest ↗
 
Via Benzinga
News headline image
Here's How Much You Would Have Made Owning Medpace Hldgs Stock In The Last 5 Years ↗
 
Via Benzinga
News headline image
Avantor Stock Earns 84 RS Rating ↗
Avantor stock had its Relative Strength (RS) Rating upgraded from 78 to 84 Tuesday amid positive Q2 earnings results. 
Via Investor's Business Daily
News headline image
MEDP Investors Have Opportunity to Join Medpace Holdings, Inc. Securities Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
News headline image
Ford, Stellantis And Dell Are Among Top 12 Large Cap Losers Last Week (July 21-July 27): Are The Others In Your Portfolio? ↗
Top 10 worst performers last week: EW (-28.05%), F (-19.12%), STM (-17.60%), TER (-16.25%), MBLY (-14.61%), STLA (-13.07%), VRT (-12.04%), SMCI (-11.68%), WST (-11.37%), DELL (-11.26%), UPS (-10.96%),... 
Via Benzinga
News headline image
Stocks Bounce As Wall Street Awaits Key Tech Earnings ↗
Stocks are firmly higher today, with the Nasdaq Composite Index (IXIC) up triple digits, as Wall Street unpacks a flood of corporate earnings reports. 
Via Talk Markets
Topics Stocks
News headline image
How Is The Market Feeling About Medpace Hldgs? ↗
 
Via Benzinga
News headline image
If You Invested $100 In This Stock 5 Years Ago, You Would Have $700 Today ↗
 
Via Benzinga
News headline image
Small-Cap Gains Resume Ahead Of Major Tech Earnings; UPS Faces Worst Day Ever, Bitcoin Dips Below $66,000: What's Driving Markets Tuesday? ↗
Tuesday's Wall Street session was mixed, with small-caps outperforming large-caps as investors awaited earnings from Alphabet Inc. and Tesla Inc. 
Via Benzinga
News headline image
NXP Semiconductors Posts Mixed Q2 Results, Joins Medpace And Other Big Stocks Moving Lower In Tuesday Pre-Market Session ↗
 
Via Benzinga
News headline image
US Stock Futures Little Changed As Traders Brace For Q2 Reports From Alphabet, Tesla: 'There Remains Strong Fundamental Support For Large Caps,' Says Economist ↗
The market mood turned jittery after Monday’s rebound, with index futures trading on either side of the unchanged line early Tuesday. The apprehensions reflect uncertainties regarding geopolitics,... 
Via Benzinga
Topics Artificial Intelligence
News headline image
Why Comcast Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
 
Via Benzinga
News headline image
Why SAP Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
IBD 50's Medpace Takes A Nosedive After Unexpectedly Slashing Its Sales View ↗
Medpace trimmed its sales outlook, but boosted its earnings view on a mixed report. 
Via Investor's Business Daily
News headline image
Medpace Holdings Stock Tumbles On Q2 Earnings: What Investors Need To Know ↗
Medpace Holdings shares are falling in Monday's after-hours session after the company reported mixed financial results and adjusted its forward guidance. 
Via Benzinga
News headline image
Medpace Holdings, Inc. Reports Second Quarter 2024 Results
From Medpace Holdings, Inc.
Via Business Wire
News headline image
Top Stocks To Buy For Growth As Earnings Approach ↗
With representation from a variety of sectors, here are three of these top stocks to consider as earnings approach. 
Via Talk Markets
News headline image
The 2 Most Important Questions in Investing ↗
Arm yourself with knowledge. 
Via The Motley Fool
News headline image
Medpace Holdings, Inc. to Report Second Quarter 2024 Financial Results on July 22, 2024
From Medpace Holdings, Inc.
Via Business Wire
< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
18 19 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.